| Pump avg. device cost | $4,000β$7,000 |
| Pump monthly supplies | $300β$500+ |
| MDI monthly cost | $50β$200 |
| Pump site change frequency | Every 2β3 days |
| MDI daily injections | 4β8 per day |
| CGM compatibility | Both pump & MDI |
Key Takeaways
- Insulin pumps offer continuous delivery and tighter control; injections are simpler and lower cost.
- CGM sensors work with both methods but integrate most powerfully with modern pumps.
- Your choice depends on lifestyle, A1C goals, and personal preference.
- Both methods are clinically proven β neither is universally superior.
Overview
Managing blood glucose in diabetes requires consistent insulin delivery. Two primary methods exist: insulin pumps (continuous subcutaneous insulin infusion, CSII) and multiple daily injections (MDI). Each has distinct advantages, and pairing either with a continuous glucose monitor (CGM) significantly improves outcomes.
Insulin Pumps
How They Work
Pumps deliver rapid-acting insulin 24/7 through a small catheter inserted under the skin. Users program basal rates and deliver boluses at meals via the device or a smartphone app. Advanced closed-loop systems (artificial pancreas) automatically adjust insulin based on real-time CGM data.
Advantages
- Precise, programmable basal rates for dawn phenomenon and shift work
- Fewer needle insertions (site changed every 2β3 days)
- Seamless CGM integration for automated insulin delivery (AID)
- Improved A1C and reduced hypoglycemia in clinical trials
Disadvantages
- Higher upfront and ongoing cost ($4,000β$7,000+ device; ~$300/month supplies)
- Device worn 24/7; risk of infusion site infections
- Requires significant training and troubleshooting skills
- Diabetic ketoacidosis (DKA) risk if tubing kinks or site fails
Multiple Daily Injections (MDI)
How They Work
MDI typically involves one or two daily injections of long-acting (basal) insulin plus rapid-acting injections at each meal. Standard regimens use insulin pens or syringes with fine-gauge needles.
Advantages
- Lower cost β pens, needles, and insulin are widely covered
- No wearable device; discreet and travel-friendly
- Simpler troubleshooting; no mechanical failure risk
- Effective A1C control when combined with a CGM sensor
Disadvantages
- Multiple daily injections can cause injection-site lipohypertrophy
- Less flexibility for variable daily schedules
- Cannot replicate the micro-adjustments of a pump's basal programming
Side-by-Side Comparison
| Feature | Insulin Pump | MDI |
|---|---|---|
| Delivery method | Continuous catheter | Needle injections |
| Basal flexibility | Highly programmable | Fixed or 2-rate |
| CGM integration | Full AID possible | Display only |
| Average monthly cost | $300β$500+ | $50β$200 |
| Daily needle sticks | 1 every 2β3 days | 4β8 per day |
The Role of CGM Sensors
Regardless of delivery method, pairing insulin therapy with a CGM sensor is the single biggest quality-of-life upgrade for people with diabetes. CGMs provide real-time glucose trends, reduce hypoglycemia risk, and eliminate most fingerstick testing. Explore MDS Diabetes's range of compatible CGM sensors at mdsdiabetes.com β including options that work seamlessly with leading pump platforms and MDI regimens alike.
Who Should Choose a Pump?
- Type 1 diabetes with unpredictable glucose patterns
- Frequent nocturnal hypoglycemia
- Athletes or shift workers needing variable basal rates
- Those willing to invest in technology for tighter control
Who Should Stick with MDI?
- Type 2 diabetes on insulin with stable patterns
- Budget-conscious patients without pump coverage
- Those who prefer fewer wearable devices
- Newly diagnosed patients learning insulin basics
Actionable Next Steps
Discuss both options with your endocrinologist. Request a pump trial if eligible. Add a CGM sensor immediately β it improves outcomes with either method. Visit MDS Diabetes to find CGM supplies compatible with your therapy.